These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Harper L; Cockwell P; Adu D; Savage CO Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943 [TBL] [Abstract][Full Text] [Related]
24. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation. Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911 [TBL] [Abstract][Full Text] [Related]
25. Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis. FijoŁek J; Wiatr E Cent Eur J Immunol; 2020; 45(2):218-227. PubMed ID: 33456335 [TBL] [Abstract][Full Text] [Related]
26. A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Watanabe-Kusunoki K; Abe N; Nakazawa D; Karino K; Hattanda F; Fujieda Y; Nishio S; Yasuda S; Ishizu A; Atsumi T Medicine (Baltimore); 2019 Apr; 98(17):e15328. PubMed ID: 31027105 [TBL] [Abstract][Full Text] [Related]
27. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study. Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843 [TBL] [Abstract][Full Text] [Related]
28. Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis. Osman MS; Tervaert JWC Curr Rheumatol Rep; 2019 Dec; 21(12):76. PubMed ID: 31879818 [TBL] [Abstract][Full Text] [Related]
29. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874 [TBL] [Abstract][Full Text] [Related]
30. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis. Schreiber A; Kettritz R J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471 [TBL] [Abstract][Full Text] [Related]
31. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Sangaletti S; Tripodo C; Chiodoni C; Guarnotta C; Cappetti B; Casalini P; Piconese S; Parenza M; Guiducci C; Vitali C; Colombo MP Blood; 2012 Oct; 120(15):3007-18. PubMed ID: 22932797 [TBL] [Abstract][Full Text] [Related]
32. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Csernok E; Lamprecht P; Gross WL Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659 [TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis. Tsukui D; Kimura Y; Kono H J Transl Autoimmun; 2021; 4():100094. PubMed ID: 33912820 [TBL] [Abstract][Full Text] [Related]
34. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab. van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673 [TBL] [Abstract][Full Text] [Related]
35. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. Ge S; Zhu X; Xu Q; Wang J; An C; Hu Y; Yang F; Wang X; Yang Y; Chen S; Jin R; Li H; Peng X; Liu Y; Xu J; Zhu M; Shuai Z Front Pharmacol; 2022; 13():957660. PubMed ID: 36210838 [TBL] [Abstract][Full Text] [Related]